Sensory NeuroStimulation Gets $1.5M in Credit Line

San Clemente-based Sensory NeuroStimulation, which makes a device for treating Restless Legs Syndrome (RLS), said it has established a $1.5M credit facility with Silicon Valley Bank. Terms of that new credit facility were not announced. Sensory NeuroStimulation said it will use the credit facility to support its ongoing operations. The company develops Relaxis, a device used to improve the quality of sleep in patients with Restless Legs Syndrome (RLS)--or more accurately, Willis-Ekbom Disease (WED). The neurostimulation device has been cleared by the FDA and is available via prescription.